{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:04:41Z","timestamp":1773479081838,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.eurox.2025.100442","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T07:52:20Z","timestamp":1767081140000},"page":"100442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Results of relugolix\/estradiol\/norethisterone acetate combination therapy in real-world clinical practice: Effectiveness, tolerability, and factors influencing discontinuation"],"prefix":"10.1016","volume":"29","author":[{"given":"A.","family":"Santalla-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Naveiro-Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Esquinas-Orellana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LM","family":"Ben\u00edtez-Cejas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garc\u00eda-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fern\u00e1ndez-Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eurox.2025.100442_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eurox.2025.100442_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Women\u2019s Health"},{"issue":"1","key":"10.1016\/j.eurox.2025.100442_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.maturitas.2014.06.002","article-title":"EMAS. EMAS position statement: management of uterine fibroids","volume":"79","author":"P\u00e9rez-L\u00f3pez","year":"2014","journal-title":"Maturitas"},{"issue":"12","key":"10.1016\/j.eurox.2025.100442_bib4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jogc.2022.10.012","article-title":"Efficacy and safety of oral GnRh antagonists in patients with uterine fibroids: a systematic review","volume":"44","author":"Niaz","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"issue":"15","key":"10.1016\/j.eurox.2025.100442_bib5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s40265-022-01790-4","article-title":"Relugolix\/estradiol\/norethisterone (norethindrone) Acetate: a review in symptomatic uterine fibroids","volume":"82","author":"Syed","year":"2022","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.eurox.2025.100442_bib6","doi-asserted-by":"crossref","first-page":"662.e1","DOI":"10.1016\/j.ajog.2023.08.030","article-title":"LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids","volume":"229","author":"Al-Hendy","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.eurox.2025.100442_bib7","doi-asserted-by":"crossref","first-page":"320.e1","DOI":"10.1016\/j.ajog.2022.11.1278","article-title":"Quality of life with relugolix combination therapy for uterine fibroids: liberty randomized trials","volume":"228","author":"Stewart","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.eurox.2025.100442_bib8","first-page":"290","article-title":"SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Coyne","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.eurox.2025.100442_bib9","first-page":"57","article-title":"Evaluation of bone mineral density in perimenopausal period","volume":"6","author":"Shariati-Sarabi","year":"2018","journal-title":"Arch Bone Jt Surg"},{"issue":"3","key":"10.1016\/j.eurox.2025.100442_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1132-8460(08)71138-3","article-title":"Baja masa \u00f3sea y factores ginecol\u00f3gicos asociados en mujeres climat\u00e9ricas","volume":"17","author":"Quiles Izquierdo","year":"2008","journal-title":"Rev Espa\u00f1ola De Enferm Metab\u00f3licas \u00d3Seas"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259016132500078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259016132500078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T08:48:45Z","timestamp":1773478125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259016132500078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":10,"alternative-id":["S259016132500078X"],"URL":"https:\/\/doi.org\/10.1016\/j.eurox.2025.100442","relation":{},"ISSN":["2590-1613"],"issn-type":[{"value":"2590-1613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results of relugolix\/estradiol\/norethisterone acetate combination therapy in real-world clinical practice: Effectiveness, tolerability, and factors influencing discontinuation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurox.2025.100442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100442"}}